Cat #: 11-702B
Zymo Research D6321-10 ZymoBIOMICS Spike-in Control II (Low Microbial Load), Zymo Research, 250 Preps/Unit
Cat #: 11-702B
Zymo Research D6321-10 ZymoBIOMICS Spike-in Control II (Low Microbial Load), Zymo Research, 250 Preps/Unit
Zymo Research
250 Preps/Unit
Brand: Zymo Research- Absolute Quantification: Enables cell number measurements from low bacterial load samples using Next-Gen Sequencing
- In situ Quality Control: Ensures each sample is quantified accurately
- Log Abundance Distribution: Three microbes alien to the human microbiome in log-distribution from 103 to 105 cells
$673.15
Login To Access Your Institutional Price
Zymo Research
250 Preps/Unit
Brand: Zymo Research- Absolute Quantification: Enables cell number measurements from low bacterial load samples using Next-Gen Sequencing
- In situ Quality Control: Ensures each sample is quantified accurately
- Log Abundance Distribution: Three microbes alien to the human microbiome in log-distribution from 103 to 105 cells
ZymoBIOMICS Spike-in Control II (Low Microbial Load) consists of three bacteria strains, Truepera radiovictrix, Imtechella halotolerans and Allobacillus halotolerans. When spiked into a microbial sample, this product will serve as an in situ positive control for DNA-sequencing-based microbiome measurements. Of the three chosen bacteria, Imtechella halotolerans is Gram-negative and Allobacillus halotolerans is Gram-positive. Truepera radiovictrix is resistant to lysozyme lysis and has very high GC content. They represent different challenges in NGS-based analysis. Moreover, with accurately quantified cell number and a log abundance distribution, this standard enables absolute cell number quantification in cases such as pathogen load detection.
Brand | Zymo Research Corporation |
---|---|
Biosafety | This product is not biohazardous as microbes have been fully inactivated. |
Impurity Level | < 0.01% foreign microbial DNA |
Sample Storage | -80°C |
Storage Solution | DNA/RNA Shield |
Enjoy our products? Leave a review and let us know.